RIL Double Nickase Plasmid (h): sc-411188-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- RIL Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- RIL Double Nickase Plasmid (h) and RIL Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting PDLIM4. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: RIL Antibody (D-8): sc-166582
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RIL Double Nickase Plasmid (h) | sc-411188-NIC | 20 µg | $410.00 | |||
RIL Double Nickase Plasmid (h2) | sc-411188-NIC-2 | 20 µg | $410.00 |
PDLIM4 encodes RIL, a PDZ-LIM domain adaptor protein that links actin-associated structures to signaling complexes, helping organize cytoskeletal architecture and cell adhesion dynamics. RIL associates with actin stress fibers and focal adhesion components, influencing processes such as cell shape, migration, and mechanotransduction. Altered PDLIM4 expression has been reported in multiple tumor types and is frequently studied in the context of epithelial–mesenchymal transition, invasion-associated pathways, and differentiation programs. These features make PDLIM4/RIL a useful node for dissecting cytoskeleton-coupled signaling and transcriptional responses in human cell models.
RIL Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the PDLIM4 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within PDLIM4. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt PDLIM4 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of PDLIM4-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.